Find generic entry opportunities
Anticipate generic drug launch
Drug patents …
… from Kazakhstan to Kalamazoo
Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Manage your formulary budget
Proactively manage your pharmacy inventory
Flat-rate pricing for predictable budgeting
Short-term plans for project- or client-based billing
|Abstract:||The instant invention provides a pharmaceutical composition comprised of a cholesterol absorption inhibitor and an HMG-CoA reductase inhibitor, one or more anti-oxidants, microcrystalline cellulose, hydroxypropyl methylcellulose, magnesium stearate and lactose. The composition need not contain ascorbic acid in order to obtain desirable stability.|
|Inventor(s):||Moore; William D. (Hoddesdon, Hertfordshire, GB), Fitzpatrick; Shaun (Hoddesdon, Hertfordshire, GB), Seiler; Christian (Hertford, GB), Saklatvala; Robert (Hoddesdon, Hertfordshire, GB), Petts; Catherine R. (Hoddesdon, Hertfordshire, GB)|
Patent Claim Types:|
see list of patent claims
|Composition; Dosage form; Use;|
Back Citations: 53rd percentile
Forward Citations: 1st percentile
|Patent Number||Expiration Date|
|7,229,982||June 12, 2011|
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.